• Featured Product
  • KD/KO Validated

PAK7 Rekombinanter Antikörper

PAK7 Rekombinant Antikörper für WB, FC (Intra), Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

230201A10

Kat-Nr. : 82935-1-PBS

Synonyme

PAK4/6/7, 230201A10, EC:2.7.11.1, KIAA1264, p21-activated kinase 5



Geprüfte Anwendungen

Produktinformation

82935-1-PBS bindet in WB, FC (Intra), Indirect ELISA PAK7 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen PAK7 fusion protein Ag29190
Vollständiger Name p21 protein (Cdc42/Rac)-activated kinase 7
Berechnetes Molekulargewicht 719 aa, 81 kDa
Beobachtetes Molekulargewicht70 kDa
GenBank-ZugangsnummerBC024179
Gene symbol PAK7
Gene ID (NCBI) 57144
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

PAK7, also known as PAK5, is a newly found but scarcely researched type II PAKs (PAK4, 5, 6). PAK7 was originally found in the brain, which promotes filopodia formation in nerve cells. Recently, studies have found that the expression level of PAK7 significantly increased in colorectal cancer, ovarian cancer, gastric cancer, neuroglioma, hepatocellular carcinoma, pancreatic cancer, osteosarcoma, and breast cancer. PAK7 plays an important role in tumorigenesis, invasion, and metastasis, mainly related to its mechanism of regulating cytoskeleton, inhibiting apoptosis, and promoting proliferation. The calculated molecular weight of PAK7 is 80 kDa (PMID: 29805709, PMID: 34165002).